The search for optimal combination of antiplatelet and anticoagulation regimens following PCI.
Gruberg
Luis
L
Division of Invasive Cardiology, Department of Cardiology, Rambam Medical Center, Haifa 31096, Israel. gruberg67@hotmail.com
Beyar
Rafael
R
D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D017984:Enoxaparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000925:Anticoagulants; D017984:Enoxaparin; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex